| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Journey Through the Golden Era of Myeloma Treatment: From Bench to Bedside
|
Jagannath, Sundar
|
|
|
25 |
5 |
p. 316-318
|
artikel
|
| 2 |
A Phase I Study of Romidepsin in Combination With Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed or Refractory Aggressive Lymphomas Enriched for T-Cell Lymphomas
|
Foley, Nicole
|
|
|
25 |
5 |
p. 328-336
|
artikel
|
| 3 |
A Review of Real-World Experience With Ruxolitinib for Myelofibrosis
|
Al-Ali, Haifa Kathrin
|
|
|
25 |
5 |
p. e262-e281
|
artikel
|
| 4 |
Artificial Intelligence Assessment of Chest Radiographs for COVID-19
|
Sasaki, Koji
|
|
|
25 |
5 |
p. 319-327
|
artikel
|
| 5 |
Clinical Outcomes of Patients With Newly Diagnosed Acute Myeloid Leukemia Receiving Treatment in a Safety-Net Hospital System
|
Lu, Jason
|
|
|
25 |
5 |
p. 349-356
|
artikel
|
| 6 |
Comprehensive Review of Bispecific Antibody Constructs In Multiple Myeloma: Affinities, Dosing Strategies and Future Perspectives
|
Waldschmidt, Johannes M.
|
|
|
25 |
5 |
p. 309-315
|
artikel
|
| 7 |
Consolidation With Second High Dose Therapy and Autologous Stem Cell Transplantation Is Associated With Improved Overall Survival in Patients With Multiple Myeloma in First Relapse
|
Klomberg, Koen M.
|
|
|
25 |
5 |
p. 357-364.e5
|
artikel
|
| 8 |
Corrigendum to “Pharmacokinetics and Efficacy of Generic Melphalan is Comparable to Innovator Formulation in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation” [Clin Lymphoma Myeloma Leuk. 20/2 (2020) 130-135.e1]
|
|
|
|
25 |
5 |
p. 379
|
artikel
|
| 9 |
Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group
|
Fotiou, Despina
|
|
|
25 |
5 |
p. e310-e318
|
artikel
|
| 10 |
Editorial Board
|
|
|
|
25 |
5 |
p. A1-A2
|
artikel
|
| 11 |
Effect of TKI Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation on Recurrence of Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia p190 and p210 Transcripts: A Multicentre Study
|
Zhen, Jiayi
|
|
|
25 |
5 |
p. e282-e289
|
artikel
|
| 12 |
Inotuzumab Ozogamicin as First-Line Therapy in Acute Lymphoblastic Leukemia
|
Jabbour, Elias J
|
|
|
25 |
5 |
p. e302-e309
|
artikel
|
| 13 |
Multiple Myeloma in Italy: An Epidemiological Model by Treatment Line and Refractoriness Status
|
Mina, Roberto
|
|
|
25 |
5 |
p. e253-e261
|
artikel
|
| 14 |
Novel Neurocognitive Testing Tool for Early Neurotoxicity Detection Following Anti-CD19 and Anti-BCMA Chimeric Antigen Receptor (CAR) T-cell Therapy: A Pilot Study
|
Suresh, Arvind
|
|
|
25 |
5 |
p. 365-378
|
artikel
|
| 15 |
Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Myeloid Neoplasms: A Systematic Review and Meta-Analysis
|
Shahzad, Moazzam
|
|
|
25 |
5 |
p. e319-e335
|
artikel
|
| 16 |
Real World Evidence From 2 Decades of First-Line TKI Therapy in Chronic Myeloid Leukemia (CML): Insights From ACHO's RENEHOC Registry
|
Abello Polo, Virginia
|
|
|
25 |
5 |
p. e290-e301
|
artikel
|
| 17 |
Real-World Treatment Patterns and Clinical Outcomes in Patients With Multiple Myeloma Previously Treated With Lenalidomide and an Anti-CD38 Monoclonal Antibody
|
Ramasamy, Karthik
|
|
|
25 |
5 |
p. 337-348.e2
|
artikel
|
| 18 |
SOHO State of the Art Updates and Next Questions | The Current State of CAR T-Cell Therapy and Bispecific Antibodies in Mantle Cell Lymphoma
|
Weiss, Jonathan M.
|
|
|
25 |
5 |
p. 304-308
|
artikel
|
| 19 |
SOHO State of the Art Updates and Next Questions | Updates on Myelofibrosis With Cytopenia
|
Khan, Muhammad Ali
|
|
|
25 |
5 |
p. 293-303
|
artikel
|
| 20 |
Table of Contents
|
|
|
|
25 |
5 |
p. A3-A5
|
artikel
|
Tijdschrift beschrijving